Armata Pharmaceuticals (ARMP) Operating Margin: 2013-2018
Historic Operating Margin for Armata Pharmaceuticals (ARMP) over the last 6 years, with Dec 2018 value amounting to 829.08%.
- Armata Pharmaceuticals' Operating Margin rose 1265408.00% to 829.08% in Q4 2018 from the same period last year, while for Dec 2018 it was 2,413.06%, marking a year-over-year increase of 1646176.00%. This contributed to the annual value of 762.14% for FY2024, which is 291085.00% up from last year.
- Latest data reveals that Armata Pharmaceuticals reported Operating Margin of 829.08% as of Q4 2018, which was up 4.79% from 791.21% recorded in Q3 2018.
- In the past 5 years, Armata Pharmaceuticals' Operating Margin ranged from a high of 10,901.14% in Q2 2018 and a low of -53,927.27% during Q4 2016.
- For the 3-year period, Armata Pharmaceuticals' Operating Margin averaged around -10,987.69%, with its median value being -4,262.26% (2016).
- Per our database at Business Quant, Armata Pharmaceuticals' Operating Margin spiked by 7,295,469bps in 2014 and then plummeted by 5,163,040bps in 2016.
- Quarterly analysis of 5 years shows Armata Pharmaceuticals' Operating Margin stood at -2,571.29% in 2014, then spiked by 27,441bps to -2,296.88% in 2015, then slumped by 5,163,040bps to -53,927.27% in 2016, then surged by 4,210,227bps to -11,825.00% in 2017, then spiked by 1,265,408bps to 829.08% in 2018.
- Its Operating Margin was 829.08% in Q4 2018, compared to 791.21% in Q3 2018 and 10,901.14% in Q2 2018.